Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Current healthy smoker as judged by the Principal Investigator(s) or designee(s)~* Minimum age: 30 years old~* Have smoked for the last 10 years~* Have smoked more than 10 non menthol CC/day on average (no brand restriction) over the past year~Exclusion Criteria:~* Clinically relevant medical conditions that in the opinion of the investigators would jeopardize the safety of the participant.~* Subject who has (FEV1/FVC) \< 0.7 and FEV1 \< 80% predicted value at post-bronchodilator spirometry~* Subject with asthma condition (post-bronchodilator FEV1/FVC \< 0.75 and reversibility in FEV1 ≥ 12% and \> 200 mL from pre- to post-bronchodilator values)~* Subject who took or is taking concomitant medication which may have an impact on the smoker's heath profile~* Female subject is pregnant or breast feeding.~* Female subject who does not agree to use an acceptable method of effective contraception.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- THS 2.2 (Type: EXPERIMENTAL): Ad libitum use of THS 2.2
- CC (Type: ACTIVE_COMPARATOR): Ad libitum use of CC

Based on this trial design, predict the completion outcome and termination type (if applicable).